A moderately strong upswing with the overall average gaining 2.3% with 18 gaining ground and 8 losing.
Inovio lead the way with a gain of 15%. Vir and Arcturus were up 7%, Altimmune and Novavax were both up 6%. Gritstone and Dynavax picked up 5%.
On the downside, CureVac fell 5%.
No comments:
Post a Comment